Acute lymphoblastic leukemia with an unusual t(8;14)(q11.2;q32): A Pediatric Oncology Group study

Leukemia

Volumn 14, Issue 2, 2000, Pages 238-240

  Kaleem, Z ^a,g   Shuster, J J ^b,g   Carroll, A J ^c,g   Borowitz, M J ^d,g   Pullen, D J ^e,g   Camitta, B M ^f,g   Zutter, M M ^a,g   Watson, M S ^a,g  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University of Florida ^*  (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^f Midwest Children's Cancer Center   (United States)

^g Pediatric Oncology Group   (United States)

Author keywords

Lymphoblastic leukemia; Prognosis; t(8; 14)(q11.2; q32)

Indexed keywords

ANTINEOPLASTIC AGENT; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RISK; CANCER SURVIVAL; CAUCASIAN; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; CHILDHOOD CANCER; CHROMOSOME TRANSLOCATION 8; CLINICAL ARTICLE; DOWN SYNDROME; FEMALE; FLOW CYTOMETRY; HEPATOMEGALY; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LEUKEMIA REMISSION; LEUKOCYTE COUNT; LYMPHADENOPATHY; MALE; MEDIASTINUM MASS; NEGRO; PATHOLOGY; PRE B LYMPHOCYTE; PRIORITY JOURNAL; SPLENOMEGALY;

EID: 0033962655     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401675     Document Type: Article

References (23)

1. Williams DL, Harris A, Williams KJ, Brosius MJ, Lemonds W. A direct bone marrow chromosome technique for acute lymphoblastic leukemia. Cancer Genet Cytogenet 1984; 13: 239-257.
2. Pui C-H, Williams DL, Roberson PK, Raimondi SC, Behm SH, Lewis SH, Rivera GK, Kalwinsky DK, Abromowitch M, Crist WM. Correlation of karyotype and immunophenotype in childhood acute lymphoblastic leukemia. J Clin Oncol 1988; 6: 56-61.
3. Bloomfield CD, Goldman AI, Alimena G, Berger R, Borgstrom HG, Brandt L, Catovsky D, Chapelle ADL, Dewald GW, Garson OM, Garwicz S, Golomb HM, Hossfeld DK, Lawler SD, Mitelman F, Nilsson P, Pierre RV, Philip P, Prigogina E, Rowley JD, Sakurai M, Sandberg AA, Secker-Walker LM, Tricot G, Berghe HVD, Orshoven AV, Vuopio P, Whang-Peng J. Chromosome abnormalities identify high-risk and low-risk patients with acute lymphoblastic leukemia. Blood 1986; 67: 415-420.
4. Harris MB, Shuster JJ, Carroll A, Look AT, Borowitz MJ, Crist WM, Nitschke R, Pullen J, Steuber CP, Land VJ. Trisomy of leukemic cell chromosomes 4 and 10 identifies children with B-progenitor cell acute lymphoblastic leukemia with a very low risk of treatment failure: a Pediatric Oncology Group study. Blood 1992; 79: 3316-3324.
5. Crist WM, Carroll AJ, Shuster JJ, Behn FG, Whitehead M, Vietti TJ, Look AT, Mahoney D, Ragab A, Pullen DJ, Land VJ. Poor prognosis of children with pre-B acute lymphoblastic leukemia is associated with t(1;19)(q23;p13): a Pediatric Oncology Group study. Blood 1990; 76: 117-122.
6. Bloomfield CD, Secker-Walker LM, Goldman AI, Berghe HVD, Chapelle ADL, Ruutu T, Alimena G, Garson OM, Golomb HM, Rowley JD, Kaneko Y, Whang-Peng J, Prigogina E, Philip P, Sandberg AA, Lawler SD, Mitelman F. Six-year follow-up of the clinical significance of karyotype in acute lymphoblastic leukemia. Cancer Genet Cytogenet 1989; 40: 171-185.
7. Third International Workshop on Chromosomes in Leukemia. Chromosomal abnormalities and their clinical significance in acute lymphoblastic leukemia. Cancer Res 1983; 43: 868-873.
8. Pui C-H, Crist W, Look A. Biology and clinical significance of cytogenetic abnormalities in childhood acute lymphoblastic leukemia. Blood 1990; 76: 1449-1463.
9. Kardon NB, Slepowitz G, Kochen JA. Childhood acute lymphoblastic leukemia associated with an unusual 8;14 translocation. Cancer Genet Cytogenet 1982; 6: 339-343.
10. Carroll AJ, Raimondi SC, Borowitz MJ, Amylon MD, Rivera G, Pullen DJ, Crist WM. A new nonrandom 8;14 translocation in children with acute lymphoblastic leukemia. Am J Hum Genet 1988; 43: A21 (Abstr.).
11. Hayashi Y, Pui C-H, Behm FG, Fuchs AH, Raimondi SC, Kitchingman GR, Mirro J, Williams DL. 14q32 translocations are associated with mixed-lineage expression in childhood acute leukemia. Blood 1990; 76: 150-156.
12. Wodzinski MA, Watmore AE, Lilleyman JS, Potter AM. Chromosomes in childhood acute lymphoblastic leukemia: karyotypic patterns in disease subtypes. J Clin Pathol 1991; 44: 48-51.
13. Testoni N, Zaccaria A, Martinelli G, Pelliconi S, Buzzi M, Farabegoli P, Panzica G, Tura S. t(8;14)(q11;q32) in acute lymphoid leukemia: description of two cases. Cancer Genet Cytogenet 1993; 67: 55-58.
14. Secker-Walker LM, Hawkins JM, Prentice HG, Mackie PH, Heerema NA, Provisor AJ. Two Down syndrome patients with an acquired translocation, t(8;14)(q11;q32), in early B-lineage acute lymphoblastic leukemia. Cancer Genet Cytogenet 1993; 70: 148-150.
15. Lee AC, Chan LC, Kwong KW. Down syndrome, acute lymphoblastic leukemia, and t(8;14)(q11;q32) (letter). Cancer Genet Cytogenet 1996; 88: 92.
16. Murphy SB, Bowman WP, Abromowitch M, Mirro J, Ochs J, Rivera G, Pui CH, Fairclough D, Berard CW. Results of treatment of advanced Burkitt's lymphoma and B-cell (slG+) acute lymphoblastic leukemia with high dose fractionated cyclophosphamide and coordinated high dose methotrexate and cytarabine. J Clin Oncol 1986; 4: 1732-1739.
17. Smith M. Towards a more uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia (ALL). Am Soc Clin Oncol Educational Book. Dallas, TX, 1994, pp 124-130.
18. Morris CM, Bowen J, Fitzgerald PH. Localization of human c-mos to chromosome band 8q11 in leukemic cells with the t(8;21)(q22;q22). Hum Genet 1989; 81: 339-342.
19. Hesketh R. The Oncogene and Tumor Suppressor Gene: Facts Book. Academic Press, Harcourt Brace: New York, 1997.
20. Li C-CH, Chen E, O'Connell CD, Longo DL. Detection of c-mos protooncogene expression in human cells. Oncogene 1993; 8: 1685-1691.
21. Posada J, Yew N, Ahn NG, Woude GFV, Cooper JA. Mos stimulates MAP kinase in Xenopus oocytes and activates a MAP kinase kinase in vitro. Mol Cell Biol 1993; 13: 2546-2553.
22. Huang CF, Ferrell JE. Dependence of Mos-induced Cdc2 activation on MAP kinase function in a cell-free system. EMBO J 1996; 15: 2169-2173.
23. Stenman G, Sahlin P, Mark J, Landys D. Structural alterations of the c-mos locus in benign pleomorphic adenomas with chromosome abnormalities of 8q12. Oncogene 1991; 6: 1105-1108.